Looking to publish in Clinical and Molecular Hepatology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginClinical and Molecular Hepatology is an international, peer-reviewed, open-access journal published quarterly in English. It focuses on advanced knowledge, trends, and understanding of hepatobiliary diseases, aims to support debate among clinical doctors, translational researchers, and basic scientists, and emphasizes public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific regions with high prevalence of hepatitis B viral infection and hepatocellular carcinoma. The journal gives priority to epidemiological studies of hepatobiliary diseases across Asia, Africa, parts of Europe, and the Americas, and publishes original papers, meta-analyses, letters to the editor, case reports, reviews, guidelines, editorials, and liver image and pathology articles in hepatology.
Looking to publish in Clinical and Molecular Hepatology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Clinical and Molecular Hepatology accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Letters To The Editor
Research Letter
Guidelines
Editorials
Recent Publications
Risk Assessment in MASLD and MetALD: Current Approaches and Future Directions
Huapeng Lin, Haixia Wang, Kangsen Yang, Min Li, Yanting Wang, Terry Cheuk-Fung Yip, Seung Up Kim
Clinical significance of gross morphological type beyond tumor burden in hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Seonjeong Woo, Donghyeon Kim, Chansik An, Sanghoon Jung, Su Jin Jang, Won Suk Lee, Hong Jae Chon
Letter regarding “Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort”
Lijun Ge, Yu Xu, Jinfang Yan
2026 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
-
Alcohol-Aware Risk Stratification and Subtype-Specific Care Pathways Across MASLD, MetALD, and ALD
Hyo Young Lee, Eileen Laurel Yoon, Dae Won Jun
Frequently asked questions
How long does it take to publish?
Decisions are available in approximately one month. Fast-track review provides a first decision within 7 days of submission and accepted papers are published within 2 weeks from acceptance.
Reformat to Clinical and Molecular Hepatology using Livewrite PremiumWhat are the publication costs?
Free online access to all published and ahead-of-print articles. Print subscription is free for official members of the Korean Association for the Study of the Liver, and non-members are charged an annual subscription fee.
Reformat to Clinical and Molecular Hepatology using Livewrite Premium